Oragenics settles Ladenburg dispute for $700K; regains NYSE American compliance

ORAGENICS INC

Paid $700K to Ladenburg Thalmann to settle $2.5M fee dispute; mutual release and arbitration dismissal.
Regained compliance with NYSE American Section 1003(a) as stockholders' equity exceeds $6M as of Oct 18, 2025.
Compliance restored after $16.5M Series H Preferred Stock offering in July 2025; .BC indicator to be removed.
Company now focusing on advancing ONP-002 concussion treatment into Phase IIa trials in Australia and planning U.S. Phase IIb.

item 1.01 item 3.01 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-25-018725
form_type: 8-K
ticker: OGEN
cik: 0001174940
company_name: ORAGENICS INC
filed_at: 2025-10-21T23:59:59+00:00
discovered_at: 2026-05-14T18:02:38.932821+00:00
generated_at: 2026-05-17T02:57:58.790638+00:00
sec_items: ["1.01", "3.01", "7.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-25-018725
json_url: https://secwatch.observer/filing/0001493152-25-018725.json
markdown_url: https://secwatch.observer/filing/0001493152-25-018725.md
text_url: https://secwatch.observer/filing/0001493152-25-018725.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315225018725/0001493152-25-018725-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1174940/000149315225018725/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-25-018725

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.